Transcript Company presentation April 2015

Intrapharm Laboratories
Presented to:
Presented by:
Date:
Company Overview
• ‘Originally founded in 1999
– Acquired by new owners in Apr’09
• Principals
– Kevin James, Chairman & CEO
• 30+ years experience, ex MD Wyeth UK & ROI
• Chairman Rosemont Pharmaceuticals
– Dr Shafiq Choudhary, COO
• 20+ years experience in sales & marketing, ex Pfizer, Wyeth,
J&J
• A speciality pharma company focussed on the promotion of
- mature brands, good heritage, well known niche pharmaceuticals
Lactulose
Established proven treatment for constipation over 40 years
 Derived from natural milk sugar with no additives or
preservatives
 Prebiotic: reduces colonic amino acid fermentation
 Improves natural intestinal flora
 Well tolerated in the majority of patients
 Suitable for short and long-term use
 No age-related contraindications
 Enhanced absorption of Calcium and Magnesium
Page 3
Lactulose Bottles
7.5 million bottles used each year in the UK
Patient, Carers and Nurses face many
problems with administering Lactulose from
the bottles
Now Available in Sachets
Benefits to Patients
• Correct Unit Dose Sachets: getting it
right every time
• Convenient, easy to carry and
discrete
• Ease in administering
• Less mess
• Easy to dispose of sachet vs bottle
Benefits to the NHS
• Less expensive and reduces waste in the Acute
setting
• Unit dose eliminates risk of medication errors
• Reduces risk of infection &
aids CQC compliance
• Saves Nursing/HCP time when administering
• Requires less storage space
• Eliminates disposal cost of bottles
• No additional hidden costs for associated
implements
A reduction in the risk
of infection
“Lactulose Sachets are the way forward as no patient would be at risk
of infection unlike from a crusty old bottle, which has multiple recipients
and can harbour a variety of bacteria.
It is mainly staphylococcus aureus that poses the most risk as it can
remain alive for days on an open bottle of Lactulose (wet or dry).
One can only assume that there IS a risk and therefore any
formulation/packaging that can minimise the potential for risk can only
be beneficial.”
Microbiologist, North West England
Lactulose usage
Acute
Sachets
drug of choice
Chronic
Cost of Bottle Disposal
Minimum of 20% of Lactulose remains in the bottle when disposed
Research conducted on the Leeds South and East CCG(Population of 260,500)
• Disposal cost is £1.65 per Kg
• Total annual wastage for one CCG is 24,564 Kg
• Total annual Cost to CCG £40K
Reference :Medicines Waste Disposal Company
Now Available in Sachets
Triamcinolone
Hexacetonide
 Formerly known as Lederspan
 Steroid injection
 For intra-articular, intrasynovial or periarticular for
- Rheumatoid arthritis
- Juvenile arthritis (3-12 years) intraarticular use only
- Osteoarthritis
- Synovitis, tendinitis, bursitis & epicondylitis
Key Benefits
 Longest acting of all the steroid injections (Jalva et al 1982
Barbara et al 2004)
 A longer relief from pain & inflammation
 Fine particle size therefore can use a thinner needle (23 gauge) = less painful
 Local anaesthetic not necessary
 TH is the only licenced product for JIA
 Good safety profile
 Good clinical experience worldwide
 Saving for CCG on referral costs
Longer Acting
Presentation
10 ampoules per box
Each 1ml ampoule contains 20mg/ml of Triamcinolone
Hexacetonide
Benefits to the NHS
 Most clinically effective product
 Drug costs for intra articular injection are modest when set against
the cost of hospital referrals and GP practice time.
 TH allows reduction in number of procedures thereby delivering
cost/benefits to the NHS
 Additional cost saving as no local anaesthetic required in adults
Terra- Cortril Ointment
 Indicated for Infected Eczema
 Contains two well known ingredients
3% Oxytetracycline
1% Hydrocortisone
 Ointment
 Good alternative to Fucidin (fucidic acid)
- minimises risk of resistance
 Does not contain preservatives
 Good heritage and experience with dermatologists
Key Issues
• Infected Eczema is a recurring condition
• Little alternative to Fucidin H (2% Fusidic acid & 1%
Hydrocortisone)
• Resistance to Fusidic acid is increasing
• The resistance to the Fusidic acid is a significant concern for
hospital microbiologists
Pricing
Brand Name
Chemical name
Pack size
NHS price
Fucidin H
fusidic acid 2% & hydrocortisone 1%
30g
£
5.02
Fucidin H
fusidic acid 2% & hydrocortisone 1%
60g
£
10.04
Terra-Cortril
Oxytetracycline 3% & hydrocortisone 1%
30g
£
5.01
Thank you
www.intrapharmlabs.com